revealed that transfer of breast cancer-secreted miR-105 to endothelial cells mediated by EVs efficiently disrupted the vascular permeability by inhibiting the tight junction protein ZO-1, which facilitates breast cancer intravasation in primary tumor sites and extravasation at metastatic sites. Here, TJP1 is linked to breast cancer.